CFM
CLOV icon

Catalyst Funds Management’s Clover Health Investments CLOV Stock Holding History

Catalyst Funds Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-96,981
Closed -$348K – 485
2025
Q1 		$348K Buy
+96,981
New +$389K 0.09% 243
2024
Q2 		– Sell
-56,550
Closed -$44.9K – 1238
2024
Q1 		$44.9K Buy
+56,550
New +$51.5K 0.01% 587

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Catalyst Funds Management's CLOV Position: Q2 2025 in Review

Catalyst Funds Management sold out of Clover Health Investments (CLOV) in Q2 2025, closing a stake of 96,981 shares — an estimated $348K sold.

Catalyst Funds Management first reported a position in CLOV in Q1 2024 and held it in 2 quarters. The position peaked at $348K in Q1 2025. 200 funds tracked by Wall St. Rank hold CLOV as of Q2 2025.

  • Catalyst Funds Management reported no remaining Clover Health Investments position as of Q2 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 96,981 Clover Health Investments shares in Q2 2025, an estimated $348K.
  • Catalyst Funds Management first reported a position in Clover Health Investments in Q1 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Clover Health Investments position peaked at $348K in Q1 2025.
  • 200 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2025.

Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.